BMBenjamin W. Maloney

Benjamin W. Maloney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Benjamin W. Maloney has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structured light imaging for breast-conserving surgery, part II: texture analysis and classification

    by Samuel S. Streeter, Benjamin W. Maloney, David M. McClatchy, Michael Jermyn, Brian W. Pogue, Elizabeth J. Rizzo, Wendy A. Wells, Keith D. Paulsen

    Breast-conserving surgery (BCS) in combination with radiation therapy is the most common treatment for stage I and II breast cancer.1,2 For BCS to be effective, excised tissue margins must be clear of malignancy (i.e., negative margins). However, 15% to 35% of BCS patients require a second surgery due to incomplete initial excision (i.e., one or more positive margins) as determined by histopathological analysis.3 – 8 Identification of cancer at the margin is a spatial detection problem, filtered visually by pathology technicians and pathologists performing labor-intensive searches of tissue sections. Several techniques have been proposed for improved BCS margin assessment, but significant limitations associated with each approach have prevented their widespread adoption.7 Common techniques include electrical impedance;9,10 diffuse reflectance11 and Raman spectroscopic point-sampling;12 touch-prep cytology;13 and frozen section pathology.14 Importantly, point-sampling methods lack a comprehensive and/or practical approach to wide field-of-view (FOV) detection and thus are inherently time-consuming. Touch-prep cytology and frozen section pathology are resource-intensive to process even a subsection of a BCS specimen and suffer slow turnaround times.13 Most techniques lack the speed and wide FOV required to intraoperatively interrogate an entire BCS lump.


  • Open Access

    Structured light imaging for breast-conserving surgery, part I: optical scatter and color analysis

    by Benjamin W. Maloney, Samuel S. Streeter, David M. McClatchy, Brian W. Pogue, Elizabeth J. Rizzo, Wendy A. Wells, Keith D. Paulsen

    Breast-conserving surgery (BCS) involves removing the mass of tumor along with a surrounding layer of healthy tissue margin. BCS has been shown to be as effective as a full mastectomy for treating early-stage cancers, provided that the margins are clear of malignancy.1 US consensus guidelines suggest that “tumor on ink” must not be present for invasive cancers. In other words, no invasive cancer cells should be found on the surface of the excised lump. For ductal carcinoma in situ (DCIS), a 2-mm zone of malignancy-free tissue should exist on all sides of a resected specimen for its margins to be considered clear, with DCIS distances less than 2 mm but not “on ink” reserved for clinical judgment.2,3 Better methods for intraoperative margin assessment are of growing interest because 15%–35% of patients require a second surgery due to positive margins resulting from their initial BCS procedure.4 – 8 Fast, effective detection of involved margins at the time of the first operation would save costs and reduce morbidity associated with a second procedure. The current standard-of-care histological processing for breast specimen margin assessment involves hematoxylin and eosin (H&E) staining followed by microscopic examination by a pathologist. Unfortunately, the process is lengthy and suffers from sampling limitations. A number of technological solutions have been posed and tested for intraoperative inspection of resected breast specimens, but most lack the speed and wide-field needed to interrogate an entire lump.4


  • Open Access

    Review of methods for intraoperative margin detection for breast conserving surgery

    by Benjamin W. Maloney, David M. McClatchy, Brian W. Pogue, Keith D. Paulsen, Wendy A. Wells, Richard J. Barth

    Breast conserving surgery (BCS) is an effective treatment for early-stage cancers as long as the margins of the resected tissue are free of disease according to consensus guidelines for patient management. However, 15% to 35% of patients undergo a second surgery since malignant cells are found close to or at the margins of the original resection specimen. This review highlights imaging approaches being investigated to reduce the rate of positive margins, and they are reviewed with the assumption that a new system would need high sensitivity near 95% and specificity near 85%. The problem appears to be twofold. The first is for complete, fast surface scanning for cellular, structural, and/or molecular features of cancer, in a lumpectomy volume, which is variable in size, but can be large, irregular, and amorphous. A second is for full, volumetric imaging of the specimen at high spatial resolution, to better guide internal radiologic decision-making about the spiculations and duct tracks, which may inform that surfaces are involved. These two demands are not easily solved by a single tool. Optical methods that scan large surfaces quickly are needed with cellular/molecular sensitivity to solve the first problem, but volumetric imaging with high spatial resolution for soft tissues is largely outside of the optical realm and requires x-ray, micro-CT, or magnetic resonance imaging if they can be achieved efficiently. In summary, it appears that a combination of systems into hybrid platforms may be the optimal solution for these two very different problems. This concept must be cost-effective, image specimens within minutes and be coupled to decision-making tools that help a surgeon without adding to the procedure. The potential for optical systems to be involved in this problem is emerging and clinical trials are underway in several of these technologies to see if they could reduce positive margin rates in BCS.